Searched for
CONCORD BIOTECH LISTING PRICE
Dubai’s housing market cools after long red-hot five-year rallyDubai’s residential property market is cooling after a five-year rally as buyers become more price-sensitive, negotiate harder and shift to...- US Stocks: Nasdaq, S&P end lower as tech megacap declines outweigh upbeat chip outlookIndian markets saw a mixed close on Thursday. While the Nasdaq and S&P dipped due to Big Tech's AI spending concerns, the Dow edged higher....
- US Stocks | Nasdaq futures surge 2% as chip outlook calms AI jitters; inflation data awaitedIndian markets are set for a positive opening as US futures surged, led by a 2.24% jump in the Nasdaq. Memory chip giants Micron and Qualco...
- CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
- Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SMEAvience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO,...
- SK Hynix surges 12% as US listing plan boosts valuation hopesSK Hynix shares surged as much as 12% after the memory chipmaker unveiled plans for a $29 billion US listing, boosting hopes of higher valu...
- Leapfrog Engineering shares list at 4.3% discount from IPO price on BSE SMELeapfrog Engineering Services experienced a subdued market entry, with its shares listing at a 4.3% discount to the IPO price on the BSE SM...
- Liotech Industries shares list at 20% discount from IPO price on BSE SME platformThe Rs 36.02-crore IPO received a subdued response from investors, with the issue being subscribed 1.91 times during the three-day bidding ...
- Diksha Polymers shares list at 2% premium to IPO price on BSE SME platformDiksha Polymers debuted on the BSE SME platform at a slight premium, opening at Rs 114.50 against its IPO price of Rs 112. The Rs 17.9-cror...
- Clay Craft India shares to list today. Check GMP ahead of debutThe Rs 110.11-crore NSE SME IPO was subscribed 103.06 times during the three-day bidding period, led by strong demand from non-institutiona...
- Ben Lamm and Colossal Biosciences: The billionaire tech founder behind the $10 billion plan to bring back extinct animalsTech entrepreneur Ben Lamm is spearheading Colossal Biosciences, a company aiming to bring back extinct species like the woolly mammoth thr...
- From Rs 4,900 crore to Rs 41,300 crore: How Sanjeev Bikhchandani turned 135 startups into a 743% return machineSanjeev Bikhchandani's Info Edge has achieved remarkable capital compounding, deploying Rs 4,900 crore across 135 startups since 2007, now ...
- US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on IranUS market saw a mixed close as the S&P 500 and Nasdaq dipped, primarily due to tech giants like Alphabet facing investor scrutiny over AI s...
- Micron Technology stock price jumps on Monday, shares up nearly 300 per cent for 2026U.S. Stock Market today: Micron Technology shares moved higher in premarket trading on Monday. AI-driven optimism has supported Wall Stree...
- Russia eyes ports, biotech for rupee surplus investments in IndiaRussia is eyeing India's burgeoning infrastructure, particularly its ports, for investments using accumulated rupee funds. Discussions are ...
- Susan Electricals shares to list today. Check GMP ahead of debutIf the grey market trend holds through listing, the stock could open with gains in that range, continuing the trend of strong debuts seen a...
- Karnataka explores biotech financing framework, AI-led innovation to support sector growthKarnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...
- Two Trades for Today: A maker of forged components for a 7.7% gain, a mid-cap pharma stock for a 6% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
- Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
Load More
